This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Unger, T. Articles by Gohlke, P. Search for Related Content PubMed PubMed Citation Articles by Unger, T. Articles by Gohlke, P.

Hypertension, Vol 20, 478-482, Copyright © 1992 by American Heart Association

ARTICLES

Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries

T Unger, T Mattfeldt, V Lamberty, P Bock, G Mall, W Linz, BA Scholkens and P Gohlke
Department of Pharmacology, University of Heidelberg, Frankfurt/Main, FRG.

We investigated the preventive effects of long-term treatment with the angiotensin converting enzyme inhibitor ramipril on myocardial left ventricular hypertrophy and capillary length density in spontaneously hypertensive rats. Rats were treated in utero and subsequently up to 20 weeks of age with a high dose (1 mg/kg per day) or with a low dose (0.01 mg/kg per day) of ramipril. Animals given a high dose of ramipril remained normotensive, whereas those given a low dose developed hypertension in parallel to vehicle-treated controls. At the end of the treatment period, converting enzyme activity in heart tissue was inhibited dose-dependently in the treated groups. Both groups revealed an increase in myocardial capillary length density together with increased myocardial glycogen and reduced citric acid concentrations. Left ventricular mass was reduced only in high dose- but not in low dose-treated animals. Our results demonstrate that early onset treatment with a converting enzyme inhibitor can induce myocardial capillary proliferation, even at doses too low to antagonize the development of hypertension or left ventricular hypertrophy. We hypothesize that potentiation of kinins is responsible for this effect, probably by augmenting myocardial blood flow, which is a well-known trigger mechanism of angiogenesis in the heart.

This article has been cited by other articles:

				F. Feihl, L. Liaudet, B. Waeber, and B. I. Levy Hypertension: A Disease of the Microcirculation? Hypertension, December 1, 2006; 48(6): 1012 - 1017. [Full Text] [PDF]

				W. Linz, S. Schafer, F. Afkham, M. Gerl, H.-L. Schmidts, and H. Rutten Vasopeptidase Inhibition Prevents Target Organ Damage and Improves Survival in Spontaneously Hypertensive Rats Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 155 - 161. [Abstract] [PDF]

				E. Kaschina, M. Stoll, M. Sommerfeld, U. M. Steckelings, R. Kreutz, and T. Unger Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis Physiol Genomics, September 16, 2004; 19(1): 41 - 49. [Abstract] [Full Text] [PDF]

				T. Unger and Jun Li The role of the renin-angiotensin-aldosterone system in heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S7 - S10. [Abstract] [PDF]

				T. WALTHER, A. MENRAD, H.-D. ORZECHOWSKI, G. SIEMEISTER, M. PAUL, and M. SCHIRNER Differential regulation of in vivo angiogenesis by angiotensin II receptors FASEB J, November 1, 2003; 17(14): 2061 - 2067. [Abstract] [Full Text] [PDF]

				S. Schafer, W. Linz, A. Bube, M. Gerl, J. Huber, G. U. Kurzel, M. Bleich, H.-L. Schmidts, A. E Busch, and H. Rutten Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats Cardiovasc Res, November 1, 2003; 60(2): 447 - 454. [Abstract] [Full Text] [PDF]

				G. Bledsoe, L. Chao, and J. Chao Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1479 - H1488. [Abstract] [Full Text] [PDF]

				H. Sato, H. Yaoita, K. Maehara, and Y. Maruyama Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H359 - H368. [Abstract] [Full Text] [PDF]

				S. Takeshita, H. Tomiyama, N. Yokoyama, Y. Kawamura, T. Furukawa, Y. Ishigai, T. Shibano, T. Isshiki, and T. Sato Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats Cardiovasc Res, November 1, 2001; 52(2): 314 - 320. [Abstract] [Full Text] [PDF]

				C. Emanueli, M. B. Salis, T. Stacca, L. Gaspa, J. Chao, L. Chao, A. Piana, and P. Madeddu Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer Hypertension, July 1, 2001; 38(1): 136 - 141. [Abstract] [Full Text] [PDF]

				J. E. Bishop, L. A. Kiernan, H. E. Montgomery, P. Gohlke, and J. R. McEwan Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats Cardiovasc Res, July 1, 2000; 47(1): 57 - 67. [Abstract] [Full Text] [PDF]

				N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats Cardiovasc Res, December 1, 1999; 44(3): 543 - 548. [Abstract] [Full Text] [PDF]

				D. J. Campbell, A.-M. Duncan, and A. Kladis Angiotensin-Converting Enzyme Inhibition Modifies Angiotensin but Not Kinin Peptide Levels in Human Atrial Tissue Hypertension, August 1, 1999; 34(2): 171 - 175. [Abstract] [Full Text] [PDF]

				H.J.M. G. Nelissen-Vrancken, M. C. Kuizinga, M. J.A.P. Daemen, and J. F.M. Smits Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts Cardiovasc Res, October 1, 1998; 40(1): 156 - 164. [Abstract] [Full Text] [PDF]

				N. Makino, M. Sugano, S. Otsuka, and T. Hata Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats Hypertension, October 1, 1997; 30(4): 796 - 802. [Abstract] [Full Text]

				P. Gohlke, I. Kuwer, A. Schnell, K. Amann, G. Mall, and T. Unger Blockade of Bradykinin B2 Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, January 1, 1997; 29(1): 478 - 482. [Abstract] [Full Text] [PDF]

				T. Ogawa, W. Linz, M. Stevenson, B. G. Bruneau, M. L. Kuroski de Bold, J. H. Chen, H. Eid, B. A. Scholkens, and A. J. de Bold Evidence for Load-Dependent and Load-Independent Determinants of Cardiac Natriuretic Peptide Production Circulation, June 1, 1996; 93(11): 2059 - 2067. [Abstract] [Full Text]

				B. J. Materson and R. A. Preston Angiotensin-Converting Enzyme Inhibitors in Hypertension: A Dozen Years of Experience Arch Intern Med, March 14, 1994; 154(5): 513 - 523. [Abstract] [PDF]